OCEA Company Profile and Key Details
Ocean Biomedical, Inc.
OCEA Stock Price Chart
Stock Price Today
Ocean Biomedical, Inc. (OCEA) stock declined over -3.13%, trading at $0.47 on NASDAQ, down from the previous close of $0.48. The stock opened at $0.50, fluctuating between $0.43 and $0.50 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP, as well as a product candidate for the treatment of COVID-19 in hospitalized patients. The company was incorporated in 2019 and is based in Providence, Rhode Island.
Company Information
| Employees | 9 |
| Beta | 1.53 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Ocean Biomedical, Inc. (NASDAQ: OCEA) stock price is $0.47 in the last trading session. During the trading session, OCEA stock reached the peak price of $0.50 while $0.43 was the lowest point it dropped to. The percentage change in OCEA stock occurred in the recent session was -3.13% while the dollar amount for the price change in OCEA stock was -$0.02.
The NASDAQ listed OCEA is part of Biotechnology industry that operates in the broader Healthcare sector. Ocean Biomedical, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Jack A. Elias M.D.
Founder, Chairman of Scientific Advisory Board & Independent Director
Dr. Jonathan Kurtis M.D., Ph.D.
Founder, Chairman of Scientific Advisory Board & Director
Dr. Inderjote Kathuria M.B.A., M.D.
Chief Strategy Officer
Mr. Kevin Kertscher
Communications Director
Mr. Gurinder Singh Kalra M.B.A.
Chief Financial Officer & Treasurer
Ms. Elizabeth Ng M.B.A.
Chief Executive Officer & Director
Mr. Robert John Sweeney
Chief Accounting Officer & Assistant Sec.
Mr. Daniel Behr M.B.A.
Executive Vice President, Head of External Innovation & Academic Partnerships and Sec.
OCEA's closing price is 7.84% higher than its 52-week low of $0.43 where as its distance from 52-week high of $7.79 is -94.03%.
Number of OCEA employees currently stands at 9.
Official Website of OCEA is: http://www.oceanbiomedical.com
OCEA could be contacted at phone 401 444 7375 and can also be accessed through its website. OCEA operates from Room 325, 55 Claverick Street, Providence, RI 02903, United States.
OCEA stock volume for the day was 169.65K shares. The average number of OCEA shares traded daily for last 3 months was 240.43K.
The market value of OCEA currently stands at $16.19M with its latest stock price at $0.47 and 34.82M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com